for inclusion – Page 5 – Communicable Diseases Research

A systematic review and metanalysis of diagnostic yield of BAL for detection of SARS-CoV-2

SARS-CoV-2 검출을 위한 BAL 진단율의 체계적인 검토 및 메타분석

Review

Published on 2022-03-012022-09-11
Journal: Heart & lung : the journal of critical care [Category] SARS, 치료기술,

Long-Term Care Facilities (LTCFs) During the COVID-19 Pandemic—Lessons From the Asian Approach: A Narrative Review

Review article

Published on 2022-03-012022-10-05
Journal: Journal of the American Medical Directors Associat [Category] SARS, 변종,

High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial

Randomized Controlled Trial

Published on 2022-03-012022-10-04
Journal: The Lancet. Respiratory Medicine [Category] COVID19(2023년), SARS, 바이오마커, 임상, 치료법,

[키워드] 1:1 age Analysis anti-SARS-CoV-2 IgG assigned baseline convalescent plasma COVID-19 COVID-19 vaccine crowdfunding did not reduce double-blind early treatment Efficacy eligible Endpoint enrolment Euroimmun Evidence experimental group experimental intervention for inclusion Grifols health-care hospitalisation in viral incidence intention-to-treat population intravenous IQR less log Methylene Mild mild COVID-19 symptom monitoring board multicentre Nasopharyngeal swab occurred Older Outpatient participant Patient Placebo placebo-controlled trial plasma Prevent progression random assignment randomisation randomised Randomly receive recommendation reduce Registered reported risk saline solution SARS-CoV-2 viral load Serious Adverse Event severe disease Spain Stratification Support symptom duration the mean Thromboembolic event titre Treatment Trial Viral load was done web-based system with COVID-19
[DOI] 10.1016/S2213-2600(21)00545-2 PMC 바로가기 [Article Type] Randomized Controlled Trial

D-dimer, CRP, PCT, and IL-6 Levels at Admission to ICU Can Predict In-Hospital Mortality in Patients with COVID-19 Pneumonia

Research Article

Published on 2022-02-282022-10-29
Journal: Oxidative Medicine and Cellular Longevity [Category] COVID-19, COVID19(2023년), MERS, SARS,

[키워드] age Belgrade Can center clinical Clinical outcome COVID-19 outbreak COVID-19 patients criteria Critically ill Critically ill patient CRP cutoff value D-dimer diagnosis of COVID-19 discharged disease effective female FEU for inclusion Health care hospital Hospitalization ICU identify IL-6 IMPROVE in-hospital death prediction in-hospital mortality intensive care unit Level log-rank test male management median age Mortality Patient patients died patients treated PCT predict predictor procalcitonin recognize Result retrospective cohort study ROC Curve statistically significant survival the Kaplan-Meier method Treatment was determined were used with COVID-19
[DOI] 10.1155/2022/8997709 PMC 바로가기 [Article Type] Research Article

The relationship between frailty, nutritional status, co-morbidity, CT-body composition and systemic inflammation in patients with COVID-19

Research

Published on 2022-02-212022-10-30
Journal: Journal of Translational Medicine [Category] COVID-19, COVID19(2023년), MERS, SARS,

Predictors of Short-Term Alcohol Drinking in Patients with Alcohol Use Disorders during the Third Wave of the COVID-19 Pandemic: Prospective Study in Three Addiction Outpatient Centers in France

Article

Published on 2022-02-102022-10-29
Journal: International Journal of Environmental Research an [Category] Coronavirus, COVID19(2023년), MERS, SARS,

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

브라질에서 코로나 박 코비드 -19 백신의 이전 수용자 (RHH-001)의 이전 수용자에서 이종과 동종 코비드 -19 부스터 백신 접종

Clinical Trial

Published on 2022-02-052022-08-13
Journal: Lancet (London, England) [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 임상, 진단, 치료기술,

[키워드] 95% CI Ad26 Ad26.COV2-S Ad26.COV2-S vaccine Administered administration adverse events age All participant All participants anti-Spike IgG anti-spike IgG antibodies Anti-spike IgG antibody anti-spike IgG response Anti-spike IgG responses Antibody concentrations assigned AstraZeneca AZD1222 B.1.1.529 B.1.617.2 baseline binding blind BNT162b2 boost booster booster dose booster vaccination Booster vaccine Brazil ChAdOx1 ChAdOx1 nCoV-19 ChAdOx1 nCoV-19 vaccine Concentration CoronaVac COVID-19 COVID-19 vaccine detectable discharged home dose eligible ENhance except for finding FIVE for inclusion four groups funding geometric geometric mean geometric mean ratio geometric mean ratios group Heterologous homologous homologous booster responses IgG antibody IgG responses immune response immune responses immunogenicity IMPROVE inactivated Infection inferiority janssen Live virus neutralising antibodies Local local and systemic reactogenicity profiles Ministry of Health mRNA vaccine Neutralising Antibodies neutralising antibody neutralising antibody titre neutralising antibody titres non-inferiority non-inferiority margin Older Older adults Omicron variant Omicron variants outcome participant Pfizer Pfizer–BioNTech phase 4 primary analysis Primary outcome profiles pseudovirus neutralising antibodies randomisation randomised Randomly reached recipient recombinant adenoviral vectored vaccine recombinant adenoviral-vectored ChAdOx1 nCoV-19 vaccine regimen Registered RHH-001 robust secondary Secondary outcomes Serious Adverse Events Seropositivity significant increase Sinovac stratified systemic reactogenicity the vaccine Vaccine vectored vaccine virus neutralising antibody whole-virion SARS-CoV-2 vaccine
[DOI] 10.1016/S0140-6736(22)00094-0 PMC 바로가기 [Article Type] Clinical Trial

High level SARS-CoV-2 nucleocapsid refolding using mild condition for inclusion bodies solubilization: Application of high pressure at pH 9.0

고급 SARS-COV-2 NucleoCapsid 포함 물체 용량을위한 온화한 상태를 사용한 폴딩 : pH 9.0에서 고압의 적용

Research Article

Published on 2022-02-032022-09-10
Journal: PLoS ONE [Category] COVID19(2023년), MERS, SARS, 진단, 치료법,

[키워드] aggregate alkaline antibody Antibody binding Antigen application association Bacterial best binding condition conserved Coronaviruses Culture culture media described Diagnosis dialysis Disulfide E . coli effective electrostatic repulsion ELISA expressed for inclusion fragment of Host hydrophobic Inclusion inclusion bodies ionic interaction kDa knowledge media Mild motif non-specific Patient presenting promote promoted Protein purification purity SARS-CoV-2 SARS-CoV-2 N SARS-CoV-2 nucleocapsid sera solubilization tertiary structure Viral Viral protein western blotting yield
[DOI] 10.1371/journal.pone.0262591 PMC 바로가기 [Article Type] Research Article

Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial

COVID-19 관련 중등도에서 중증 급성 호흡 곤란 증후군(ICAR) 환자의 정맥 면역글로불린: 다기관, 이중 맹검, 위약 대조, 3상 시험

Clinical Trial

Published on 2022-02-012022-09-12
Journal: The Lancet. Respiratory Medicine [Category] COVID19(2023년), MERS, SARS, 임상, 진단,

[키워드] 1:1 acute respiratory distress Administered administration adverse event adverse events ARDS Clinique complication of COVID-19 COVID-19 disease stage distress double-blind eligible event for inclusion France Frequency high mortality Immunoglobulin IMPROVE improve clinical outcome Inclusion intention-to-treat analysis intention-to-treat principle Intravenous immunoglobulin Invasive mechanical ventilation Lung injury morbidity multicentre no statistical difference not significant outcome Patient patients patients with COVID-19 PCR phase 3 trial Placebo placebo-controlled placebo-controlled trial Primary outcome Randomly randomly assigned patient receive receiving reducing Registered risk Serious Adverse Events Sodium chloride stratified syndrome the median the placebo group Treatment Trial trials Volume was done web-based system women
[DOI] 10.1016/S2213-2600(21)00440-9 PMC 바로가기 [Article Type] Clinical Trial

Changes in Frequency and Patterns of Marital Sexual Activity During COVID-19: Evidence From Longitudinal Data Prior to, During and After Lockdown in Singapore

COVID-19 동안의 결혼 성행위의 빈도와 패턴의 변화: 싱가포르의 폐쇄 전, 중, 후 종단 데이터의 증거

Article

Published on 2022-02-012022-09-11
Journal: The journal of sexual medicine [Category] COVID19(2023년), SARS, 치료기술,

[키워드] activity affected applied baseline Birth weight change changes changes in clinical collected conditions COVID-19 dataset demographic characteristics Effect exclusion criteria Factor Factors fatigue female participant flexible Follow-up for inclusion Frequency Health implication inclusion and exclusion criteria increase in infertility information lifted lockdown longitudinal Longitudinal data longitudinal study Low birth weight Marital marital satisfaction online questionnaire pandemic participant pattern predicted Pregnancy Prevalence Previous studies Probability proportion provide recall recruited relationship Relationship Satisfaction remained reproductive Result Satisfaction screened Sex sexual Sexual Activity Sexual Behavior sexual desire Sexual Frequency Singapore strength Stress unique were recorded were used women
[DOI] 10.1016/j.jsxm.2021.12.004 PMC 바로가기 [Article Type] Article